Literature DB >> 29137858

Human Papillomavirus E6 and E7 oncoproteins affect the cell microenvironment by classical secretion and extracellular vesicles delivery of inflammatory mediators.

Marco Iuliano1, Giorgio Mangino1, Maria Vincenza Chiantore2, Maria Simona Zangrillo1, Rosita Accardi3, Massimo Tommasino3, Gianna Fiorucci4, Giovanna Romeo5.   

Abstract

The connection between chronic inflammation and risk of cancer has been supported by several studies. The development of cancer might be a process driven by the presence of a specific combination of inflammatory mediators, including cytokines, chemokines and enzymes, in the tumor microenvironment. Virus-induced tumors, like HPV-induced Squamous Cell Carcinomas, represent a paradigmatic example of the interplay between inflammation, as integral part of the innate antiviral response, and malignant transformation. Here, the role of inflammatory microenvironment in the HPV-induced carcinogenesis is addressed, with a specific focus on the involvement of the immune molecules as well as their delivery through the microvesicle cargo possibly correlated to the different HPV genotype. The expression of the inflammatory mediators in HPV positive cells has been analyzed in primary human foreskin keratinocytes and keratinocytes transduced by E6 and E7 from mucosal HPV-16 or cutaneous HPV-38 genotypes. HPV E6 and E7 proteins can modulate the expression of immune mediators in HPV-infected cells and can affect the levels of immune molecules, mainly chemokines, in the extracellular milieu. HPV-16 E6 and E7 oncoproteins have been silenced to confirm the specificity of the modulation of the inflammatory microenvironment. Our results suggest that the expression of HPV oncoproteins allows the modification of the tumor milieu through the synthesis and release of specific pro-inflammatory cytokines and chemokines, affecting the efficacy of the immune response. The microenvironment can also be conditioned by an altered mRNA cargo delivered by extracellular vesicles, thereby efficiently affecting the surrounding cells with possible implication for tumorigenesis and tumor diagnosis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extracellular vesicles; Human Papilloma Virus; Inflammatory mediators; Tumor virology

Mesh:

Substances:

Year:  2017        PMID: 29137858     DOI: 10.1016/j.cyto.2017.11.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

Review 1.  Effects of Exosomal Viral Components on the Tumor Microenvironment.

Authors:  Jing Li; Yan Zhang; Bing Luo
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

2.  Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model.

Authors:  Lorena Capriotti; Marco Iuliano; Roberto Lande; Loredana Frasca; Mario Falchi; Paolo Rosa; Giorgio Mangino; Giovanna Romeo
Journal:  J Inflamm Res       Date:  2022-09-16

Review 3.  Extracellular Vesicles in Cervical Cancer and HPV Infection.

Authors:  Víctor Acevedo-Sánchez; Ruth M Rodríguez-Hernández; Sergio R Aguilar-Ruíz; Honorio Torres-Aguilar; María de Los A Romero-Tlalolini
Journal:  Membranes (Basel)       Date:  2021-06-20

Review 4.  Human Papillomavirus and carcinogenesis: Novel mechanisms of cell communication involving extracellular vesicles.

Authors:  Maria Vincenza Chiantore; Giorgio Mangino; Marco Iuliano; Lorena Capriotti; Paola Di Bonito; Gianna Fiorucci; Giovanna Romeo
Journal:  Cytokine Growth Factor Rev       Date:  2020-01-18       Impact factor: 7.638

Review 5.  A review of the research progress in T-lymphocyte immunity and cervical cancer.

Authors:  Lina Zhang; Zhilei Mao; Yiqing Lai; Ting Wan; Keliang Zhang; Beibei Zhou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

Review 6.  Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles.

Authors:  Naoomi Tominaga
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.